×

Believe in strong Europe reimbursement: Dendreon CEO

5:29 PM ET Wed, 5 March 2014

Biotech firm Dendreon is set to begin selling its prostate cancer vaccine "Provenge" in Europe. John Johnson, Dendreon chairman & CEO, discusses the European launch and addresses investor concerns.